Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Rush

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Biochemistry|February 1, 1991
Cyclosporine toxicity to organs other than the kidneyD N Rush
Cellular Immunology|August 1, 1984
Human monocyte chemiluminescence triggered by IgG aggregates. Requirement of phospholipase activation and modulation by Fc receptor ligandsD N Rush, P A Keown
Transplantation|February 27, 1995
Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schemaD N Rush, J R Jeffery, J Gough
Clinical Chemistry|November 1, 1984
Effects of sample preparation on concentrations of cyclosporin A measured in plasmaR W Yatscoff, D N Rush, J R Jeffery
Nephron|January 1, 1994
Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patientsR M McKenna, C Macdonald, K N Bernstein, et al.
Nephron|January 1, 1993
Production of tumor necrosis factor alpha and hemodialysisC Macdonald, D N Rush, K N Bernstein, et al.
Transplantation|February 1, 1989
Inhibition of cytokine production by cyclosporine A and GR M McKenna, K Szturm, J R Jeffery, et al.
Transplantation|June 1, 1987
Increased monocyte Fc-dependent chemiluminescence in renal transplant patientsD N Rush, J M Cook, D A Niven, et al.
Transplantation|October 31, 2001
The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patientsS Torng, C Rigatto, D N Rush, et al.
Transplantation|January 1, 1988
Interleukin 2, interferon, and lymphotoxin in renal transplant recipientsR M McKenna, D N Rush, P Bakkestad-Legare, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Biochemistry|February 1, 1991
Cyclosporine toxicity to organs other than the kidneyD N Rush
Cellular Immunology|August 1, 1984
Human monocyte chemiluminescence triggered by IgG aggregates. Requirement of phospholipase activation and modulation by Fc receptor ligandsD N Rush, P A Keown
Transplantation|February 27, 1995
Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schemaD N Rush, J R Jeffery, J Gough
Clinical Chemistry|November 1, 1984
Effects of sample preparation on concentrations of cyclosporin A measured in plasmaR W Yatscoff, D N Rush, J R Jeffery
Nephron|January 1, 1994
Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patientsR M McKenna, C Macdonald, K N Bernstein, et al.
Nephron|January 1, 1993
Production of tumor necrosis factor alpha and hemodialysisC Macdonald, D N Rush, K N Bernstein, et al.
Transplantation|February 1, 1989
Inhibition of cytokine production by cyclosporine A and GR M McKenna, K Szturm, J R Jeffery, et al.
Transplantation|June 1, 1987
Increased monocyte Fc-dependent chemiluminescence in renal transplant patientsD N Rush, J M Cook, D A Niven, et al.
Transplantation|October 31, 2001
The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patientsS Torng, C Rigatto, D N Rush, et al.
Transplantation|January 1, 1988
Interleukin 2, interferon, and lymphotoxin in renal transplant recipientsR M McKenna, D N Rush, P Bakkestad-Legare, et al.
Pageof 3